» Articles » PMID: 34205263

Growth Abnormalities As a Risk Factor of Adverse Neonatal Outcome in Hypertensive Pregnancies-A Single-Center Retrospective Cohort Study

Overview
Specialty Health Services
Date 2021 Jul 2
PMID 34205263
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: Hypertensive disorders of pregnancy (HDP) include gestational hypertension (GH), chronic hypertension (CH), preeclampsia (PE), and preeclampsia superimposed on chronic hypertension (CH with PE). HDP is associated with several short and long-term perinatal and neonatal complications, such as newborn growth restriction and death. This study aimed to establish the association between HDP, newborn growth abnormalities, and neonatal outcome. (2) Methods: This is a single-center retrospective cohort study of 63651 singleton deliveries. (3) Results: Univariate analysis showed a significantly increased risk of intrauterine and neonatal death associated with maternal hypertension and growth disorders. There were differences between growth charts used, with the highest risk of stillbirth for SGA defined by the Intergrowth chart (OR 17.2) and neonatal death for newborn growth restriction (NGR) based on Intergrowth (OR 19.1). Multivariate analysis showed that NGR is a stronger risk factor of neonatal death than SGA only. (4) Conclusions: HDP is significantly associated with growth abnormalities and is an independent risk factor of adverse outcomes. The presence of newborn growth restriction is strongly associated with the risk of neonatal death. The choice of growth chart has a substantial effect on the percentage of diagnosis of SGA and NGR.

Citing Articles

Does Exposure to Ambient Air Pollution Affect Gestational Age and Newborn Weight?-A Systematic Review.

Grabowski B, Feduniw S, Orzel A, Drab M, Modzelewski J, Pruc M Healthcare (Basel). 2024; 12(12).

PMID: 38921290 PMC: 11203000. DOI: 10.3390/healthcare12121176.


Appropriate Delivery Timing in Fetuses with Fetal Growth Restriction to Reduce Neonatal Complications: A Case-Control Study in Romania.

Bujorescu D, Ratiu A, Citu C, Gorun F, Gorun O, Crisan D J Pers Med. 2023; 13(4).

PMID: 37109031 PMC: 10145500. DOI: 10.3390/jpm13040645.

References
1.
Fenton T, Kim J . A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013; 13:59. PMC: 3637477. DOI: 10.1186/1471-2431-13-59. View

2.
Chiefari E, Quaresima P, Visconti F, Mirabelli M, Brunetti A . Gestational diabetes and fetal overgrowth: time to rethink screening guidelines. Lancet Diabetes Endocrinol. 2020; 8(7):561-562. DOI: 10.1016/S2213-8587(20)30189-3. View

3.
Barnhart L . HELLP Syndrome and the Effects on the Neonate. Neonatal Netw. 2016; 34(5):269-73. DOI: 10.1891/0730-0832.34.5.269. View

4.
Yu C, Khouri O, Onwudiwe N, Spiliopoulos Y, Nicolaides K . Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol. 2008; 31(3):310-3. DOI: 10.1002/uog.5252. View

5.
Major C, de Veciana M, Lewis D, Morgan M . Preterm premature rupture of membranes and abruptio placentae: is there an association between these pregnancy complications?. Am J Obstet Gynecol. 1995; 172(2 Pt 1):672-6. DOI: 10.1016/0002-9378(95)90591-x. View